Glenn Sblendorio's Net Worth
$15.5 Million
Estimate Recalculated Nov 11, 2024 08:47AM EST
Who is Glenn Sblendorio?
Glenn Sblendorio has an estimated net worth of $15.5 Million. This is based on reported shares across multiple companies, which include EYETECH PHARMACEUTICALS INC, Mineralys Therapeutics, Inc., INTERCEPT PHARMACEUTICALS, INC., AMICUS THERAPEUTICS, INC., Ophthotech Corp., and MEDICINES CO /DE.
SEC CIK
Glenn Sblendorio's CIK is 0001277478
Past Insider Trading and Trends
2011 was Glenn Sblendorio's most active year for acquiring shares with 22 total transactions. Glenn Sblendorio's most active month to acquire stocks was the month of May. 2023 was Glenn Sblendorio's most active year for disposing of shares, totalling 32 transactions. Glenn Sblendorio's most active month to dispose stocks was the month of November. 2013 saw Glenn Sblendorio paying a total of $5,610,643.14 for 322,876 shares, this is the most they've acquired in one year. In 2015 Glenn Sblendorio cashed out on 399,886 shares for a total of $7,937,453.26, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EYETECH PHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -154.50K |
—
|
—
|
0
|
Nov 14
| |||
Form 4
| +258.50% | 111.4K |
$9.52 | -$909,421.00 | 154.5K |
Nov 3 - Nov 4
| |||
Form 4
|
—
|
0
|
$6.36 | -$36,963.00 | 43.09K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$6.98 | -$41,551.00 | 43.09K |
Scheduled
|
Jul 1
| ||
Form 4
| +7,142.86% | 42.5K |
$0.01 | $425.00 | 43.09K |
Jun 28
| |||
Form 4
|
—
|
0
|
$7.15 | -$42,846.00 | 595 |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
$23.27 | -$219,050.00 |
0
|
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$21.31 | -$299,175.00 |
0
|
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mineralys Therapeutics, Inc. (MLYS) Snapshot price: $11.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -31.56K |
$19.00 | -$599,602.00 |
0
|
Nov 8
| |||
Form 4
| +34.59% | 8.11K |
—
|
—
| 31.56K |
May 24
| |||
Form 4
| +49.25% | 7.74K |
—
|
—
| 23.45K |
May 25
| |||
Form 4
| +80.97% | 7.03K |
—
|
—
| 15.71K |
May 27
| |||
Form 4
| +22.51% | 1.59K |
—
|
—
| 8.68K |
May 28
| |||
Form 4
| +28.46% | 1.57K |
—
|
—
| 7.09K |
Jun 20
| |||
Form 4
| +47.92% | 1.79K |
—
|
—
| 5.52K |
Jun 20
| |||
Form 4
| +61.71% | 1.42K |
—
|
—
| 3.73K |
Jun 27
| |||
Form 4
| +109.26% | 1.2K |
—
|
—
| 2.31K |
Jul 19
| |||
Form 4
| +143.81% | 650 |
—
|
—
| 1.1K |
Nov 24
| |||
Form 4
|
∞
| 452 |
—
|
—
| 452 |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS, INC. (FOLD) Snapshot price: $11.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.17% | 11.85K |
—
|
—
| 95.44K |
Jun 6
| |||
Form 4
| +21.87% | 15K |
$2.80 | $42,000.00 | 83.6K |
Mar 7
| |||
Form 4
| +9.90% | 8.58K |
—
|
—
| 95.3K |
Jun 8
| |||
Form 4
| +20.91% | 15K |
$3.32 | $49,800.00 | 86.72K |
May 18
| |||
Form 4
| +21.46% | 12.67K |
—
|
—
| 71.72K |
Jun 9
| |||
Form 4
| +34.05% | 15K |
$4.79 | $71,850.00 | 59.05K |
Mar 4
| |||
Form 4
| +29.81% | 10.12K |
—
|
—
| 44.05K |
Jun 10
| |||
Form 4
| +20.85% | 5.86K |
—
|
—
| 33.93K |
Jun 4
| |||
Form 4
| +28.63% | 6.25K |
—
|
—
| 28.08K |
Jun 27
| |||
Form 4
| +52.99% | 3.08K |
—
|
—
| 8.89K |
Jun 7
| |||
Form 4
| +48.72% | 5.81K |
—
|
—
| 17.75K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
$15.00 |
—
| 11.93K |
Scheduled
|
Jul 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
$12.50 |
—
| 11.93K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
$6.50 |
—
| 11.93K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -9.77% | -1.40K |
$16.74 | -$23,438.80 | 12.93K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +7.50% | 1K |
$11.40 | $11,395.05 | 14.33K |
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ophthotech Corp. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -239.28K |
—
|
—
|
0
|
Jul 11
| |||
Form 4
| +4.86% | 11.08K |
$13.22 | $146,486.14 | 239.28K |
Jun 22
| |||
Form 4
| +6.56% | 14.05K |
$20.06 | -$349,986.82 | 228.19K |
Jan 2 - Jan 3
| |||
Form 4
| -12.29% | -30.00K |
—
|
—
| 214.14K |
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +7.58% | 17.2K |
$21.51 | -$418,520.07 | 244.14K |
Dec 18 - Dec 19
| |||
Form 4
| +25.91% | 46.7K |
—
|
—
| 226.94K |
Dec 9 - Dec 12
| |||
Form 4
| -21.77% | -50.00K |
$23.01 | -$1,150,500.00 | 179.69K |
Scheduled
|
Nov 2
| ||
Form 4
| -17.88% | -50.00K |
$18.76 | -$937,805.00 | 229.69K |
Scheduled
|
Apr 4
| ||
Form 4
|
—
|
0
|
$10.21 | -$630,178.99 | 279.69K |
Scheduled
|
Mar 30 - Apr 1
| ||
Form 4
|
—
|
0
|
$10.00 | -$265,103.00 | 279.69K |
Scheduled
|
Mar 25
| ||
Form 4
|
—
|
0
|
$9.97 | -$48,916.83 | 279.69K |
Scheduled
|
Mar 18
| ||
Form 4
|
—
|
0
|
$9.98 | -$12,673.06 | 279.13K |
Scheduled
|
Dec 30 - Dec 31
| ||
Form 4
| -17.69% | -60.00K |
$9.22 | -$882,487.69 | 279.13K |
Scheduled
|
Dec 22 - Dec 27
| ||
Form 4
| +5.65% | 18.13K |
$15.44 | -$286,075.39 | 339.13K |
Dec 18 - Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +4.78% | 14.66K |
$14.74 | -$122,279.46 | 321K |
Dec 12 - Dec 13
| |||
Form 4
| +8.40% | 23.75K |
—
|
—
| 306.34K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +9.15% | 22.95K |
—
|
—
| 273.77K |
Dec 12
| |||
Form 4
| +10.46% | 23.75K |
—
|
—
| 250.82K |
Dec 9
| |||
Form 4
| +9.09% | 18.75K |
—
|
—
| 225.06K |
Apr 1
| |||
Form 4
| +12.98% | 22.95K |
—
|
—
| 199.8K |
Dec 12
| |||
Form 4
| +54.65% | 62.5K |
$4.00 | $250,000.00 | 176.85K |
Dec 9 - Dec 10
| |||
Form 4
| +15.10% | 15K |
$3.12 | $46,851.00 | 114.35K |
Nov 15
| |||
Form 4
| +36.71% | 25K |
$1.48 | $37,000.00 | 93.11K |
May 10
| |||
Form 4
| +21.03% | 11.84K |
$1.43 | -$9,887.02 | 68.11K |
Apr 1 - Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| +32.64% | 11.91K |
$2.69 | -$18,394.22 | 48.41K |
Apr 1 - Apr 2
| |||
Form 4
| +51.03% | 12.33K |
$3.19 | -$25,803.91 | 36.49K |
Dec 29 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
| +108.81% | 12.59K |
$2.58 | -$20,196.24 | 24.16K |
Jun 30 - Jul 5
| |||
Form 4
| +5,410.48% | 11.36K |
$3.56 | -$26,301.28 | 11.57K |
Apr 1 - Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| -100.00% | -1.08K |
$4.85 | -$5,236.49 |
0
|
Dec 22
| |||
Form 4
|
∞
| 1.08K |
$57.20 | -$38,381.20 | 1.08K |
Jun 1 - Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
$46.61 | -$133,568.00 |
0
|
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
$41.74 | -$153,568.00 |
0
|
Scheduled
|
Sep 30 - Jul 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||